Therapeutic effect of topiramate as adjunctive therapy in adults with refractory partial epilepsy

赵翕平,石静萍,陈惠玲,李作汉,管青山

DOI: https://doi.org/10.3969/j.issn.1004-1648.2001.02.007

2001-01-01

Journal of Clinical Neurology

Abstract:Objective　To observe the effectiveness,safety and tolerability of Topiramate(TPM) as adjunctive therapy in adults with refractory partial epilepsy with or without secondary generalized tonic-clinic seizure (GTCS).Methods　TPM as adjunctive therapy in 56 cases (original therapy with antiepileptic drugs) for 20 weeks,the first 8 weeks for titration phase, the last 12 weeks for stabilization phase of maintain therapy. In baseline phase the seizure frequency, dosage situation,weight were noted,and as the contrast of self.With 25 mg/d TPM as a starting dosage and titration,the target dosage was 200 mg/d.The blood concentration of the AEDs blood compared before and after the treatment,and the therapy was analysed widely by the end of the treatment.Results　After TPM adjunctive therapy for 20 weeks,as compared with the seizure frequency in baseline phase,the seizure frequencies of 64.29% patients were reduced ≥50%;the seizure frequencies of 25% patients ≥75%<100%;16.07% were free.The adverse responses were from mild to moderate,but it related to the dosage of AEDs.The weight of 50% patients reduced in different degree.The effects of the blood concentration weren't great on TPM to carbamazepine and valproate.Conclusion TPM is a safe effective drug for treating adult patients with refractory partial epilepsy with or without secondary GTCS.